0000899243-17-018643.txt : 20170720
0000899243-17-018643.hdr.sgml : 20170720
20170720170051
ACCESSION NUMBER: 0000899243-17-018643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170718
FILED AS OF DATE: 20170720
DATE AS OF CHANGE: 20170720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MADDEN DAVID
CENTRAL INDEX KEY: 0001230836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 17974787
MAIL ADDRESS:
STREET 1: ADOLOR CORP
STREET 2: 700 PENNSYLVANIA DRIVE
CITY: EXTON
STATE: PA
ZIP: 19431
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-18
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001230836
MADDEN DAVID
C/O DICERNA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
1
0
0
0
Director Stock Option (right to buy)
3.42
2017-07-18
4
A
0
33000
0.00
A
2027-07-18
Common Stock
33000
33000
D
This option vests monthly over 12 months from July 11, 2017 in substantially equal monthly installments, subject to the Reporting Person's continued service to the Issuer through each such date.
/s/ John B. Green, attorney-in-fact
2017-07-20